Apixaban and Dapsone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Apixaban (apixaban) and Dapsone (dapsone). Common drug interactions include platelet count decreased among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Apixaban and Dapsone. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

44 people who take Apixaban and Dapsone together, and have interactions are studied.

Apixaban and Dapsone drug interactions.

What are the common drug interactions of Apixaban and Dapsone, by gender? *:

female:

  1. Platelet count decreased
  2. Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
  3. Pyrexia (fever)
  4. Red blood cell count decreased
  5. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  6. Septic shock (shock due to blood infection)
  7. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
  8. Stem cell transplant
  9. Vomiting
  10. Anxiety

male:

  1. Pneumonia
  2. Disease progression
  3. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  4. Decreased appetite
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  7. Fall
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Femur fracture
  10. Haemolytic anaemia (anaemia due to haemolysis)

What are the common drug interactions of Apixaban and Dapsone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)

50-59:

  1. Anxiety
  2. Blood creatinine increased
  3. Constipation
  4. Cytomegalovirus test positive
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Dyspnoea (difficult or laboured respiration)
  7. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  8. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  9. Fatigue (feeling of tiredness)
  10. Hypercholesterolaemia (high levels of cholesterol in the blood)

60+:

  1. Fatigue (feeling of tiredness)
  2. Pneumonia
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Eczema nummular (circular or oval patches of eczema with well-defined edges)
  6. Erythema (redness of the skin)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Multiple allergies (allergy to multiple agents)
  9. Skin discolouration (change of skin colour)
  10. Skin exfoliation (removal of the oldest dead skin cells)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 14 people, 31.82%
  2. Anaemia (lack of blood): 8 people, 18.18%
  3. Neuropathy Peripheral (surface nerve damage): 8 people, 18.18%
  4. Hyperglycemia (high blood sugar): 8 people, 18.18%
  5. Prostate Cancer: 8 people, 18.18%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 18.18%
  7. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 8 people, 18.18%
  8. Multiple Myeloma (cancer of the plasma cells): 6 people, 13.64%
  9. Bleeding Disorders: 4 people, 9.09%
  10. Breast Cancer: 4 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and Dapsone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Apixaban and Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apixaban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on apixaban and dapsone (the active ingredients of Apixaban and Dapsone, respectively), and Apixaban and Dapsone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: